Join Redalpine Senior Investment Manager Marc Mösser in conversation with three founders at the frontier of one of the most exciting intersections in modern science - techbio. Garry, CEO of Dalton; Rick, CEO of Helical; and Ula, CEO of LevelZeroHealth, take to the Protein Studios stage for an intimate 25-minute session that goes beyond the science to explore what it truly takes to build and scale a techbio company in the UK. Backed and supported by Redalpine, one of Europe's leading deep tech venture funds, these three founders offer a rare window into the founder-investor relationship at its most formative - the moments of conviction, the pivots, and the partnership that makes the difference between a promising idea and a category-defining company. For venture and angel investors, this is a front-row seat to three of the most promising companies emerging from the techbio space, and a masterclass in what a high-conviction VC bet looks like up close. For founders, it's an honest account of what building in the UK's techbio ecosystem really demands - and why the opportunity has never been greater.
RB
RB
Health & Medtech